T1	HMM 0 38	Pharmacokinetic and safety assessments
T2	HMM 457 474	drug interactions
T3	HMM 792 805	ratios of AUC
T4	HMM 1084 1131	treatment ratios of Cmax and associated 90% CIs
T5	HMM 1325 1340	pharmacokinetic
T6	HMM 1447 1515	Adverse events (predominantly headache, nervousness, and somnolence)
T7	HMM 1597 1636	clinically meaningful drug interactions
